MyMaskFit

MyMaskFit as featured on the BBC Debate Night For more information please don't hesitate to contact us on our route to scale up volume production with Made Smarter UK, and Innovate UK Support. See the debate here - MedSupplyDrive UK - 'Save Lives and Save the Planet' https://lnkd.in/dm2wXWnj #Mask #Respirator #P3 #COVID #airbornetransmission #NHS Department of Health and Social Care #COP26 #resuable #health

Some hospitals have reintroduced mask wearing after a spike in patients being admitted with Covid-19, so should we be worried the virus is making a comeback? Since Monday, patients, visitors and staff are required to wear masks in clinical areas at the Royal Stoke University Hospital and County Hospital in Stafford. In Worcestershire, the Acute Hospitals NHS Trust said the measure was necessary "to protect patients, their loved ones and hospital staff from risk of infection". They are currently treating 65 patients with Covid-19, the highest number since December 2021. Patients are also in hospital for longer so that would indicate they are sicker too. In Staffordshire, there are 108 patients with the virus. At Royal Stoke Hospital two wards are currently full with Covid patients. But it is difficult to tell if this is some sort of "summer Covid wave" because we are doing a lot less testing than we used to. Most of the testing these days is done of hospital patients when they are admitted and yes, we are seeing a bit of an uptick, indeed it might be higher than the numbers suggest as not all new patients are tested. Part of life But let's put these new cases in context. With about 170 infected patients in the last few weeks in Staffordshire and Worcestershire that is a lot fewer than we saw at the height of the pandemic. At the end of 2021 going in to 2022, we saw a peak in England of nearly 300,000 new cases a day and there are no signs we are even remotely close to a return to those sort of numbers. As for what is driving this small rise in cases, well Covid-19 as a virus is constantly evolving and yes that means new variants. If you remember it was the Omicron variant that drove that huge peak of 300,000 cases. Currently, we are seeing a descendent of that Omicron variant, JN1, dominating things and in fact, there are even newer mutations of JN1, that we are keeping an eye on collectively, called FliRT. But the truth is Covid-19 is now part of life. We will all be infected and re-infected over and over again. For many of us, that is not likely to be a problem, but those that can, should keep getting boosted, and yes, in hospital mask wearing is something we might see more of now and again as infection rates peak. #Covid19 #MasksInTheHospital #PublicHealth #Vaccination

Moderna hails successful trial of combined Covid and flu shot Moderna's Combined Covid-19 and Flu Vaccine Matches Single Shot Efficacy in Phase 3 Trial, Moving Closer to Regulatory Approval 🔹 Phase 3 Success: Moderna's combined Covid-19 and flu vaccine demonstrated efficacy similar to single-shot administration in late-stage trials involving over 8,000 adults aged 50 and over. 🔹 Higher Efficacy Against Flu Strains: The combination vaccine showed higher efficacy targeting three specific seasonal flu strains, including H1N1 swine flu. 🔹 Regulatory Pathway: Interim data publication and U.S. regulatory submission are planned for later this year, with potential FDA approval by next summer. 🔹 Market Opportunity: The combined vaccine aims to enter the $8 billion seasonal flu market by the 2025 winter season, providing a competitive edge through added convenience. 🔹 Diverse Pipeline: Moderna is expanding beyond Covid products, leveraging its mRNA vaccine platform to address other viruses and diseases, including cancer. 🔹 Strategic Growth: Recent approval of Moderna's second product targeting respiratory syncytial virus and high investor interest in its H5 pandemic flu vaccine candidate. 🔹 Positive Market Response: Moderna’s share price up 37% this year, driven by promising pipeline developments and positive phase 3 trial results for the combined vaccine. #Moderna #VaccineInnovation #mRNA #Covid19 #FluVaccine #Healthcare #Biotech #FDAApproval #MarketGrowth #PublicHealth #FluSeason #InvestorNews #MedicalResearch #RSVVaccine

New Covid variants stoke fears of a summer surge in cases So-called FLiRT strains set to test effectiveness of vaccines against latest mutations New Covid-19 variants are spreading around the world and stoking fears of a summer surge in cases in the US, in the latest sign of the infectious disease’s ability to mutate and potentially threaten collective immunity. KP. 2, one of several so-called FLiRT variants — the word derives from the names of the mutations in the variants’ genetic code — has become the dominant coronavirus strain in the US since first emerging in March. In the two weeks to May 11, KP. 2 accounted for 28.2 per cent of cases, up from just 3.8 per cent in the two weeks to the end of March, according to the latest data from the US Centers for Disease Control and Prevention. The KP1.1 variant has also grown rapidly to account for 7.6 per cent of infections. The agency is closely monitoring the FLiRT variants — including the KP strains and previously dominant JN.1 strain that are all offshoots of the dominant Omicron Covid strain — but does not believe there is evidence that it will drive a surge in cases of severe disease. Four-and-a-half years after the outbreak of the pandemic, caseloads in the US have in recent months fallen close to record lows. But while many infectious disease experts do not expect a surge in hospital admissions, they caution this new cluster of variants could drive a summer wave of infections. A key question is how effective current vaccines will be against the new strains. Lawrence Young, a virologist at Warwick university, said booster shots would continue to give worthwhile protection, at least against severe disease. However William Schaffner, an infectious disease specialist at Vanderbilt university in Nashville, Tennessee, argued that protection “is not as guaranteed against these subvariants because the mutations are a little bit more distant from the kind of antibody protection we got from prior infection and from vaccination”. “But that evidence is from lab studies, we need to see what happens in the field,” added Schaffner. #FLIRT #CoVID #Omricon

Female nurses in Scotland were regularly being given face masks designed for men during the Covid pandemic, a public inquiry has heard. The Royal College of Nursing (RCN) told the Scottish Covid Inquiry that female nurses were warning their masks would not always fit properly as a result. RCN Scotland director Colin Poolman said the inadequacy of PPE given to its members "was staggering" at times. Better PPE would have cut the number of NHS staff getting Covid, the RCN added. Scotland's Covid public inquiry is investigating what happened during the country's response to the pandemic, to work out what lessons can be learned for future public health emergencies. #covid #masks #ppe